The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States AJ Siegler, F Mouhanna, RM Giler, K Weiss, E Pembleton, J Guest, ... Annals of epidemiology 28 (12), 841-849, 2018 | 374 | 2018 |
Update: COVID-19 among workers in meat and poultry processing facilities―United States, April–May 2020 MA Waltenburg MMWR. Morbidity and mortality weekly report 69, 2020 | 308 | 2020 |
Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017 PS Sullivan, RM Giler, F Mouhanna, ES Pembleton, JL Guest, J Jones, ... Annals of epidemiology 28 (12), 833-840, 2018 | 223 | 2018 |
Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 212 | 2014 |
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients SM Ingle, MT May, MJ Gill, MJ Mugavero, C Lewden, S Abgrall, ... Clinical Infectious Diseases 59 (2), 287-297, 2014 | 205 | 2014 |
Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study KB Anderson, JL Guest, D Rimland Clinical Infectious Diseases 39 (10), 1507-1513, 2004 | 193 | 2004 |
HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database A Alonso, AE Barnes, JL Guest, A Shah, IY Shao, V Marconi Journal of the American Heart Association 8 (14), e012241, 2019 | 187 | 2019 |
The three steps needed to end the COVID-19 pandemic: bold public health leadership, rapid innovations, and courageous political will JL Guest, C Del Rio, T Sanchez JMIR Public health and surveillance 6 (2), e19043, 2020 | 172 | 2020 |
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies A Boulle, M Schomaker, MT May, RS Hogg, BE Shepherd, S Monge, ... PLoS medicine 11 (9), e1001718, 2014 | 146 | 2014 |
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies A Trickey, CA Sabin, G Burkholder, H Crane, AA Monforte, M Egger, ... The Lancet HIV 10 (5), e295-e307, 2023 | 135 | 2023 |
Similarities and differences in COVID-19 awareness, concern, and symptoms by race and ethnicity in the United States: cross-sectional survey J Jones, PS Sullivan, TH Sanchez, JL Guest, EW Hall, N Luisi, ... Journal of medical Internet research 22 (7), e20001, 2020 | 113 | 2020 |
CD4: CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus–infected patients on antiretroviral therapy: the Antiretroviral Therapy Cohort … A Trickey, MT May, P Schommers, J Tate, SM Ingle, JL Guest, MJ Gill, ... Clinical Infectious Diseases 65 (6), 959-966, 2017 | 111 | 2017 |
Cohort profile: antiretroviral therapy cohort collaboration (ART-CC) MT May, SM Ingle, D Costagliola, AC Justice, F de Wolf, M Cavassini, ... International journal of epidemiology 43 (3), 691-702, 2014 | 102 | 2014 |
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009 Antiretroviral Therapy Cohort Collaboration (ART-CC Aids 27 (5), 803-813, 2013 | 102 | 2013 |
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ... The Lancet 376 (9738), 340-345, 2010 | 98 | 2010 |
Recurrent Kawasaki disease: USA and Japan RA Maddox, RC Holman, R Uehara, LS Callinan, JL Guest, ... Pediatrics International 57 (6), 1116-1120, 2015 | 95 | 2015 |
Detection of SARS-CoV-2 RNA and antibodies in diverse samples: protocol to validate the sufficiency of provider-observed, home-collected blood, saliva, and oropharyngeal samples PS Sullivan, C Sailey, JL Guest, J Guarner, C Kelley, AJ Siegler, ... JMIR public health and surveillance 6 (2), e19054, 2020 | 93 | 2020 |
Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected patients followed for up to 15 years after start of treatment: collaborative … MT May, JJ Vehreschild, A Trickey, N Obel, P Reiss, F Bonnet, ... Clinical Infectious Diseases 62 (12), 1571-1577, 2016 | 90 | 2016 |
At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process … M Valentine-Graves, E Hall, JL Guest, E Adam, R Valencia, K Shinn, ... PloS one 15 (8), e0236775, 2020 | 89 | 2020 |
Prevalence and predictors of food insecurity in migrant farmworkers in Georgia BG Hill, AG Moloney, T Mize, T Himelick, JL Guest American journal of public health 101 (5), 831-833, 2011 | 75 | 2011 |